SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Art of Investing
PICK 46.190.0%Nov 11 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Sun Tzu9/6/2024 9:00:09 AM
  Read Replies (1) of 10553
 
Amylyx Pharmaceuticals Director Buys 100,000 Shares
Sep 5, 202419:30 EDT
AMLX+5.26%

Reporter NameMilne George M Jr
RelationshipDirector
TypePurchase
Amount$219,800
SEC Filing Form 4

George M. Jr Milne, a Director at Amylyx Pharmaceuticals, purchased 100,000 shares of Common Stock on September 3, 2024, at a weighted average price of $2.198 per share, totaling $219,800. Following this transaction, Milne directly owns 858,571 shares of the company. The price range for the shares was from $2.14 to $2.235.

SEC Filing: Amylyx Pharmaceuticals, Inc. [ AMLX ] - Form 4 - Sep. 05, 2024

=================

Disclaimer - I own some AMLX
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News